X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (117) 117
humans (107) 107
hematology (88) 88
transplantation (74) 74
adult (73) 73
immunology (68) 68
middle aged (66) 66
male (65) 65
female (62) 62
bone-marrow-transplantation (38) 38
adolescent (37) 37
hematology, oncology and palliative medicine (37) 37
aged (36) 36
hematopoietic stem cells (35) 35
hematopoietic stem cell transplantation (34) 34
versus-host-disease (32) 32
abridged index medicus (30) 30
animals (26) 26
transplantation, homologous (26) 26
hematopoietic stem cell transplantation - methods (25) 25
hematopoietic stem cell transplantation - adverse effects (21) 21
article (20) 20
stem cells (20) 20
young adult (20) 20
allergy and immunology (19) 19
bone marrow (19) 19
t cells (18) 18
immune reconstitution (17) 17
natural or artificial threads or fibres (17) 17
paper (17) 17
spinning (17) 17
spinning or twisting (17) 17
stem-cell transplantation (17) 17
textiles (17) 17
treatment outcome (17) 17
antithymocyte globulin (16) 16
child (16) 16
chronic disease (15) 15
health aspects (15) 15
peripheral-blood (15) 15
research (15) 15
cancer (14) 14
leukemia (14) 14
time factors (14) 14
transplantation, autologous (14) 14
antilymphocyte serum - administration & dosage (13) 13
transplantation conditioning - methods (13) 13
disease-free survival (12) 12
follow-up studies (12) 12
recipients (12) 12
retrospective studies (12) 12
t-lymphocytes - immunology (12) 12
transplantation conditioning (12) 12
unrelated donors (12) 12
allogeneic transplantation (11) 11
reconstitution (11) 11
risk factors (11) 11
analysis (10) 10
bone marrow transplantation (10) 10
flow cytometry (10) 10
graft vs host disease - etiology (10) 10
graft vs host disease - prevention & control (10) 10
hematologic neoplasms - therapy (10) 10
hematopoietic cell transplantation (10) 10
incidence (10) 10
lymphocyte count (10) 10
stem cell transplantation (10) 10
survival analysis (10) 10
tissue donors (10) 10
vidarabine - analogs & derivatives (10) 10
b-lymphocytes - immunology (9) 9
bone-marrow (9) 9
cd4 lymphocyte count (9) 9
graft vs host disease - mortality (9) 9
immunity (9) 9
medical research (9) 9
multiple sclerosis (9) 9
oncology (9) 9
prophylaxis (9) 9
rabbits (9) 9
survival (9) 9
t-cells (9) 9
acute disease (8) 8
b-cells (8) 8
bone marrow transplantation - immunology (8) 8
bone-marrow transplantation (8) 8
cd4-positive t-lymphocytes - immunology (8) 8
child, preschool (8) 8
graft vs host disease - immunology (8) 8
infection (8) 8
marrow-transplantation (8) 8
mortality (8) 8
survival rate (8) 8
whole-body irradiation (8) 8
acute myeloid-leukemia (7) 7
antilymphocyte serum - therapeutic use (7) 7
blood (7) 7
busulfan (7) 7
busulfan - administration & dosage (7) 7
cell biology (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, The, ISSN 1474-4422, 2009, Volume 8, Issue 3, pp. 244 - 253
Summary Background Autologous non-myeloablative haemopoietic stem cell transplantation is a method to deliver intense immune suppression. We evaluated the... 
Neurology | MULTICENTER | MEDICAL PROGRESS | AUTOIMMUNE-DISEASES | DOSE IMMUNOSUPPRESSIVE THERAPY | DISABILITY | FOLLOW-UP | MARROW-TRANSPLANTATION | CONDITIONING REGIMEN | CLINICAL NEUROLOGY | BLOOD | Disability Evaluation | Multiple Sclerosis, Relapsing-Remitting - pathology | Rabbits | Antibodies, Neoplasm - therapeutic use | Follow-Up Studies | Multiple Sclerosis, Relapsing-Remitting - therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Magnetic Resonance Imaging - methods | Antibodies, Monoclonal - therapeutic use | Male | Transplantation, Autologous | Treatment Outcome | Alemtuzumab | Cyclophosphamide - therapeutic use | Young Adult | Antibodies, Monoclonal, Humanized | Disease-Free Survival | Animals | Antilymphocyte Serum - therapeutic use | Adult | Female | Hematopoietic Stem Cell Transplantation - methods | Medical colleges | Multiple sclerosis | Neurosciences | Immunotherapy | Stem cells | Interferon beta | Transplantation | Biological response modifiers | Medicine, Preventive | Preventive health services | Index Medicus | Corticoids | Autografts | Inventories | stem cell transplantation | Clinical trials | Diarrhea | Leukocytes | Quality of life | Neurological diseases | Thrombocytopenic purpura | Cyclophosphamide | Immunosuppression | Hospitals | beta -Interferon | Magnetic resonance imaging | Neurological complications | Peripheral blood | Monoclonal antibodies | Remission | Platelets | Antilymphocyte serum
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 06/2019, Volume 25, Issue 6, pp. e216 - e217
Journal Article
Nature Genetics, ISSN 1061-4036, 10/2011, Volume 43, Issue 10, pp. 1012 - 1019
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 1, pp. 35 - 47
Scleroderma is a life-threatening autoimmune disease in need of more effective treatment. A randomized trial of myeloablative therapy followed by autologous... 
MEDICINE, GENERAL & INTERNAL | END-POINT | AUTOIMMUNE-DISEASES | DOSE IMMUNOSUPPRESSIVE THERAPY | CLINICAL-TRIALS | HEART-FAILURE | DOUBLE-BLIND | LUNG-DISEASE | MARROW-TRANSPLANTATION | PULSE CYCLOPHOSPHAMIDE | SEVERE SYSTEMIC-SCLEROSIS | Follow-Up Studies | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Kaplan-Meier Estimate | Male | Transplantation, Autologous | Hematopoietic Stem Cell Transplantation - mortality | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Infection - etiology | Young Adult | Disease-Free Survival | Scleroderma, Systemic - therapy | Scleroderma, Systemic - mortality | Adolescent | Hematopoietic Stem Cell Transplantation - adverse effects | Intention to Treat Analysis | Adult | Female | Immunosuppressive Agents - adverse effects | Aged | Transplantation Conditioning | Scleroderma, Systemic - drug therapy | Treatment outcome | Care and treatment | Systemic scleroderma | Analysis | Patient outcomes | Scleroderma (Disease) | Stem cells | Transplantation | CD34 antigen | Medical research | Autografts | Kidneys | Transplants & implants | Toxicity | Hypersensitivity | Stem cell transplantation | Sclerosis | Immunosuppressive agents | Hemopoiesis | Cyclophosphamide | Immunosuppression | Infectious diseases | Systemic sclerosis | Renal failure | Skin | Scleroderma | Heart diseases | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 137, Issue 2, pp. AB2 - AB2
  PBMNCs from KIR typed healthy volunteers were stimulated with EBV transformed target cells to enumerate NK cell response to EBV (degranulation) and/or IFNγ... 
Allergy and Immunology | Health aspects | Genes | T cell receptors
Journal Article
Journal Article